Issue 5
Alpha¹ Editorial
Intranasal Anti-CD3 Antibody Treatment for Post-COVID Neuroinflammation
Get the top 1% of preprints in your inbox
Create a free Αlpha¹ Science account to follow peer-validated research, receive editorial curations, and participate as a reviewer or author.